Sensex on Tuesday, crossed the 43000 mark for the first time in history. The immense growth was experienced after the successful COVID-19 vaccine trial by Pfizer, the company claimed that the vaccine was more than 90 percent effective based on initial trial results and also led by strong FII’s and strong quarter results.
The Bombay Stock Exchange gained 400 points and breached the 43,000 level for the first time. Sensex was at 43,158.41 at 12:50 IST, up by 560.98 points with a growth of 1.32 percent. While Nifty was 140.50 points higher at 12:53 IST, at 12,601.55, up by 1.13 percent.
Bajaj Finance, IndusInd Bank, and SBI were the top gainers. Bajaj Finance surged 9.18 percent to 4219.90 up by 354.90 points. IndusInd bank surged almost 10 percent to 852.95 with a positive growth of 77.50 points. State Bank of India added 6.22 percent high at 233.15.
The surge in marked reported on the US-based pharma company Pfizer’s vaccine launch against COVID-19. The vaccine named BNT162b2 showed good results in the first interim efficacy analysis conducted on November 8, 2020, by an external independent Data Monitoring Committee (DMC) from the Phase three clinical study.
“Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis,” Pfizer said in a statement.t New